# | Title | Journal | Year | Citations |
---|
1 | Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity | Proceedings of the National Academy of Sciences of the United States of America | 2017 | 88 |
2 | Impact of aging on mitochondrial function in cardiac and skeletal muscle | Free Radical Biology and Medicine | 2016 | 54 |
3 | The VPS-34 PI3 kinase negatively regulates RAB-5 during endosome maturation | Journal of Cell Science | 2017 | 40 |
4 | CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target | EBioMedicine | 2017 | 38 |
5 | Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection | PLoS Pathogens | 2020 | 33 |
6 | What Are the Functions of Chitin Deacetylases in Aspergillus fumigatus? | Frontiers in Cellular and Infection Microbiology | 2020 | 23 |
7 | A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis | EBioMedicine | 2019 | 22 |
8 | Mechanisms of T REG cell adaptation to inflammation | Journal of Leukocyte Biology | 2020 | 19 |
9 | Eicosanoid receptors as therapeutic targets for asthma | Clinical Science | 2021 | 16 |
10 | Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes | Biochemical Pharmacology | 2015 | 14 |
11 | Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys | Journal of Medicinal Chemistry | 2016 | 14 |
12 | Targeting the OXE receptor as a potential novel therapy for asthma | Biochemical Pharmacology | 2020 | 14 |
13 | Protein kinase C activates NAD kinase in human neutrophils | Free Radical Biology and Medicine | 2020 | 12 |
14 | A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene | Genome Medicine | 2021 | 12 |
15 | Stereoselective synthesis of two highly potent 5-oxo-ETE receptor antagonists | Tetrahedron Letters | 2015 | 11 |
16 | Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys | British Journal of Pharmacology | 2020 | 10 |
17 | Inhibition of allergen‐induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non‐human primates | British Journal of Pharmacology | 2020 | 10 |
18 | In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys | Biochemical Pharmacology | 2017 | 8 |
19 | Novel Highly Potent and Metabolically Resistant Oxoeicosanoid (OXE) Receptor Antagonists That Block the Actions of the Granulocyte Chemoattractant 5-Oxo-6,8,11,14-Eicosatetraenoic Acid (5-oxo-ETE) | Journal of Medicinal Chemistry | 2018 | 7 |
20 | Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys | European Journal of Pharmaceutical Sciences | 2018 | 6 |
21 | Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates | British Journal of Pharmacology | 2022 | 6 |
22 | Dynein-mediated trafficking negatively regulates LET-23 EGFR signaling | Molecular Biology of the Cell | 2016 | 5 |
23 | Golgi localization of the LIN-2/7/10 complex points to a role in basolateral secretion of LET-23 EGFR in the Caenorhabditis elegans vulval precursor cells | Development (Cambridge) | 2021 | 5 |
24 | An approach to measuring protein turnover in human induced pluripotent stem cell organoids by mass spectrometry | Methods | 2022 | 5 |
25 | Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood | Frontiers in Immunology | 2021 | 4 |
26 | The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population | Cancers | 2022 | 4 |
27 | Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families | Npj Breast Cancer | 2021 | 3 |
28 | Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants | Genes | 2022 | 3 |
29 | The Rab GTPase activating protein TBC-2 regulates endosomal localization of DAF-16 FOXO and lifespan | PLoS Genetics | 2022 | 3 |
30 | Parathyroid Hormone‐Related Protein Inhibition Blocks Triple‐Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal | JBMR Plus | 2022 | 2 |
31 | Long-term tumour dormancy in a BRCA1 heterozygote | Journal of Medical Genetics | 2022 | 1 |
32 | Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates | European Journal of Pharmaceutical Sciences | 2022 | 1 |